Diagnosis and management of immune thrombocytopenic purpura (ITP) remain largely
dependent on clinical expertise and observations more than on evidence derived from clinical …

Previously published guidelines for the diagnosis and management of primary immune
thrombocytopenia (ITP) require updating largely due to the introduction of new classes of …

Objective Earlier studies of eosinophilic granulomatosis with polyangiitis (Churg‐Strauss) (EGPA),
with limited patient numbers and followup durations, demonstrated that clinical …

Cases of apparent secondary immune thrombocytopenia (ITP) after SARS-CoV-2 vaccination
with both the Pfizer and Moderna versions have been reported and reached public …

Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …

Objective To assess the effectiveness of hydroxychloroquine in patients admitted to hospital
with coronavirus disease 2019 (covid-19) pneumonia who require oxygen. Design …

Objective A number of open‐label studies have suggested the potential benefit of rituximab (RTX)
in systemic lupus erythematosus (SLE). However, in 2 recent randomized controlled …

Treatments for immune thrombocytopenic purpura (ITP) providing durable platelet
responses without continued dosing are limited. Whereas complete responses (CRs) to B-cell …

Objective. To describe characteristics and outcomes of vasculitides associated with
malignancies. Methods. The requirement for inclusion in this retrospective, 10-year study was …

The epidemiology of immune thrombocytopenia (ITP) is not well known. The purpose of this
study was to assess ITP incidence at a nationwide level (France) with recent data (mid-2009 …